Delivery Order SPE2DB22D7058-SPE2DB23FV4XM

Award Date 7/31/23
Potential Completion Date 8/1/23
Potential Value $343
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $312,980 firm fixed price delivery order to Amerisourcebergen Drug Corporation for pharmaceutical products. Under this order, Amerisourcebergen will supply the Defense Logistics Agency with 4561483484 tablets of Nortrel 1-35, a contraceptive medication, to be delivered to a facility in Conshohocken, Pennsylvania. Performance is required from July 13-14, 2023. No subcontractors or set aside designations were identified. This order was placed under an...
The Defense Logistics Agency awarded a $132,860 firm fixed price delivery order to Amerisourcebergen Drug Corporation for pharmaceutical products. Under this order, Amerisourcebergen will supply the Defense Logistics Agency with 4561558970 tablets of Nortrel 1-35, a contraceptive medication, to be delivered to its facility in Conshohocken, Pennsylvania. Performance is required from July 20-21, 2023. As a major provider of medical supplies to the Department of Defense, this order supports the...
The Defense Logistics Agency awarded a $153,880 firm fixed price delivery order to Amerisourcebergen Drug Corporation for pharmaceutical products. Under this order, Amerisourcebergen will provide 4561327909 Nortrel 1-35 28 Tablet 28s to the Defense Logistics Agency. Performance will take place in Conshohocken, Pennsylvania from June 23 through June 26, 2023. No set aside designation or subcontractors were identified. This order was issued under an existing indefinite-delivery/indefinite-quantity...
The Defense Logistics Agency awarded a $362,100 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561931467 Nortrel 0.5-35-28 tablets. As part of its mission to support the logistical needs of the Department of Defense, the Defense Logistics Agency issued this order under an existing pharmaceutical supply vehicle to ensure service members have access to necessary prescription medications. Amerisourcebergen will fulfill the order from its facility in...
The Defense Logistics Agency awarded a $34,740 delivery order to Amerisourcebergen Drug Corporation for pharmaceutical products under contract number 4562091498. The firm fixed price order is to supply 4562091498 ! NORTREL 1-35 28 TABLET 28S to support the Defense Logistics Agency's medical supply needs. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of three days from September 8-11, 2023. No subcontractors or set aside designations...
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $243.18 to Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, to supply 4562003630 Nortrel 1-35 28 Tablet 28S. The place of performance is Conshohocken, Pennsylvania. The period of performance is from August 30, 2023 through August 31, 2023. No major subcontractors or set aside designations were indicated. The Defense Logistics Agency manages the global supply chain for the United...
The Defense Logistics Agency awarded a $195,310 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561784952 NORTREL 0.5-35-28 TABLET 28S. As the logistics combat support agency for the Department of Defense, the DLA supports America's armed forces by procuring their supplies, equipment, and services. This delivery order falls under an existing indefinite-delivery/indefinite-quantity contract vehicle and provides pharmaceutical products to support DOD health services....
The Defense Logistics Agency awarded a $102,330 firm fixed price delivery order to Amerisourcebergen Drug Corporation for pharmaceutical products. Under this order, Amerisourcebergen will supply 4561585374 Nortrel 0.5-35-28 tablets to the DLA. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over one day in July 2023. No set aside designation or subcontractors were identified. This order was placed under an existing DLA pharmaceuticals contract vehicle to...
The Defense Logistics Agency awarded a $71,630 delivery order to Amerisourcebergen Drug Corporation for pharmaceutical products. Under the firm fixed price contract, Amerisourcebergen will supply 4562216832 Nortrel 0.5-35-28 tablets to the DLA. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over one day in September 2023. No set aside designation or subcontractors were identified. The DLA manages the global supply chain for the Department of Defense and...
The Defense Logistics Agency awarded a $278,420 delivery order to Amerisourcebergen Drug Corporation for pharmaceutical products. Under the terms of the firm fixed price contract, Amerisourcebergen will supply 4561889455 NORTREL 0.5-35-28 TABLET 28S to the DLA. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over the period of August 21-22, 2023. As a major distributor of pharmaceuticals and medical supplies, Amerisourcebergen frequently supports the...
  • SPE2DB22D7058
    Indefinite Delivery Contract
  • SPE2DB22D7058-SPE2DB23FV4XM
    Delivery Order

The Defense Logistics Agency awarded a $343,320 delivery order to Amerisourcebergen Drug Corporation for pharmaceutical products. The firm fixed price order is for the delivery of 4561643982 Nortrel 1-35 28 Tablet 28s to a facility in Conshohocken, Pennsylvania, and has a period of performance from July 31, 2023 through August 1, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics network and supply chain, and this order is likely in support of DLA's procurement and distribution of pharmaceuticals to military treatment facilities and beneficiaries. No subcontractors or set aside designations were identified.

Generated 12/23/23, 11:37 AM